MannKind Announces Senior Management Changes
November 20 2015 - 08:00AM
MannKind Corporation (NASDAQ:MNKD) and (TASE:MNKD)
today announced that Hakan Edstrom has stepped down as the
President, Chief Executive Officer and as a director of MannKind.
The board of directors of MannKind appointed Alfred Mann as interim
Chief Executive Officer, effective November 19, 2015. Mr. Mann will
continue to serve as the Executive Chairman of the Company. A
committee of the board will commence an immediate search for a
successor CEO.
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) and (TASE:MNKD) focuses on
the discovery and development of therapeutic products for patients
with diseases such as diabetes. MannKind maintains a website at
http://www.mannkindcorp.com to which MannKind regularly posts
copies of its press releases as well as additional information
about MannKind. Interested persons can subscribe on the MannKind
website to e-mail alerts that are sent automatically when MannKind
issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the
website.
CONTACT: Company Contact:
Matthew J. Pfeffer
Chief Financial Officer
661-775-5300
mpfeffer@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Feb 2024 to Mar 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Mar 2023 to Mar 2024